Citicoline in acute ischemic stroke: A randomized controlled trial.
Ayush AgarwalVenugopalan Y VishnuJyoti SharmaRohit BhatiaAjay GargSadanand DwivediAshish UpadhyayVinay GoyalMamta Bhushan SinghAnu GuptaRoopa RajanMadakasira Vasantha Padma SrivastavaPublished in: PloS one (2022)
CAISR was the first to evaluate the role of Citicoline, when used immediately after recanalization therapy, when the penumbral tissue is the most susceptible either to be protected from injury or become ischemic. We did not find any significant difference between the Citicoline or placebo arms with respect to either our primary or secondary outcomes.